Successful correction of hemophilia by CRISPR/Cas9 genome editing in vivo : delivery vector and immune responses are the key to success

Abstract : Comment on CRISPR/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse. [EMBO Mol Med. 2016]
Document type :
Journal articles
Complete list of metadatas

Cited literature [15 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02150381
Contributor : Ana Paula Dutra Azevedo <>
Submitted on : Friday, June 7, 2019 - 11:30:53 AM
Last modification on : Saturday, June 8, 2019 - 1:25:37 AM

File

EMMM-8-439.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Tuan Nguyen, Ignacio Anegon. Successful correction of hemophilia by CRISPR/Cas9 genome editing in vivo : delivery vector and immune responses are the key to success. EMBO Molecular Medicine, Wiley Open Access, 2016, 8 (5), pp.439-441. ⟨10.15252/emmm.201606325⟩. ⟨inserm-02150381⟩

Share

Metrics

Record views

53

Files downloads

33